885 related articles for article (PubMed ID: 26824674)
1. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.
Yin RX; Li YY; Lai CQ
Lipids Health Dis; 2011 Aug; 10():140. PubMed ID: 21854571
[TBL] [Abstract][Full Text] [Related]
3. The association between apolipoprotein A1-C3-A5 gene cluster promoter polymorphisms and risk of ischemic stroke in the northern Chinese Han population.
Wang Y; Liu F; Li L; Deng S; He Z
J Int Med Res; 2017 Dec; 45(6):2042-2052. PubMed ID: 28635360
[TBL] [Abstract][Full Text] [Related]
4. Interactions between the apolipoprotein a1/c3/a5 haplotypes and alcohol consumption on serum lipid levels.
Yin RX; Li YY; Wu JZ; Pan SL; Liu CW; Lin WX; Yang DZ
Alcohol Clin Exp Res; 2013 Feb; 37(2):234-43. PubMed ID: 22924697
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
Liu Y; Ordovas JM; Gao G; Province M; Straka RJ; Tsai MY; Lai CQ; Zhang K; Borecki I; Hixson JE; Allison DB; Arnett DK
Pharmacogenet Genomics; 2009 Feb; 19(2):161-9. PubMed ID: 19057464
[TBL] [Abstract][Full Text] [Related]
6. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.
Liu ZK; Hu M; Baum L; Thomas GN; Tomlinson B
Atherosclerosis; 2010 Feb; 208(2):427-32. PubMed ID: 19732897
[TBL] [Abstract][Full Text] [Related]
7. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L; Liu S; Rifai N; Hunter D; Hu FB
Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
[TBL] [Abstract][Full Text] [Related]
8. Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome.
Ding Y; Zhu MA; Wang ZX; Zhu J; Feng JB; Li DS
J Biomed Biotechnol; 2012; 2012():509420. PubMed ID: 22675253
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific DNA methylation profiles regulate liver-specific expression of the APOA1/C3/A4/A5 cluster and can be manipulated with demethylating agents on intestinal cells.
Guardiola M; Oliva I; Guillaumet A; Martín-Trujillo Á; Rosales R; Vallvé JC; Sabench F; Del Castillo D; Zaina S; Monk D; Ribalta J
Atherosclerosis; 2014 Dec; 237(2):528-35. PubMed ID: 25463085
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms of the APOA1/C3/A4/A5-ZPR1-BUD13 gene cluster are associated with dyslipidemia in a sex-specific pattern.
Bai W; Kou C; Zhang L; You Y; Yu W; Hua W; Li Y; Yu Y; Zhao T; Wu Y
PeerJ; 2019; 6():e6175. PubMed ID: 30631647
[TBL] [Abstract][Full Text] [Related]
11. Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.
Delgado-Lista J; Perez-Jimenez F; Ruano J; Perez-Martinez P; Fuentes F; Criado-Garcia J; Parnell LD; Garcia-Rios A; Ordovas JM; Lopez-Miranda J
J Lipid Res; 2010 Jan; 51(1):63-73. PubMed ID: 19592705
[TBL] [Abstract][Full Text] [Related]
12. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
[TBL] [Abstract][Full Text] [Related]
13. The APOA1/C3/A4/A5 cluster and markers of allostatic load in the Boston Puerto Rican Health Study.
Mattei J; Demissie S; Tucker KL; Ordovas JM
Nutr Metab Cardiovasc Dis; 2011 Nov; 21(11):862-70. PubMed ID: 20674306
[TBL] [Abstract][Full Text] [Related]
14. Relationship of the APOA5/A4/C3/A1 gene cluster and APOB gene polymorphisms with dyslipidemia.
Ou HJ; Huang G; Liu W; Ma XL; Wei Y; Zhou T; Pan ZM
Genet Mol Res; 2015 Aug; 14(3):9277-90. PubMed ID: 26345861
[TBL] [Abstract][Full Text] [Related]
15. Identifying functional non-coding variants in APOA5/A4/C3/A1 gene cluster associated with coronary heart disease.
Cui G; Tian M; Hu S; Wang Y; Wang DW
J Mol Cell Cardiol; 2020 Jul; 144():54-62. PubMed ID: 32437778
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
17. The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study.
Hsu MC; Lee KT; Hsiao WC; Wu CH; Sun HY; Lin IL; Young KC
BMC Cancer; 2013 Jul; 13():330. PubMed ID: 23829168
[TBL] [Abstract][Full Text] [Related]
18. Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.
You Y; Wu YH; Zhang Y; Zhang L; Song Y; Bai W; Li Y; Yu Y; Kou C
BMJ Open; 2018 Jun; 8(6):e020016. PubMed ID: 29866721
[TBL] [Abstract][Full Text] [Related]
19. Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population.
Chien KL; Chen MF; Hsu HC; Su TC; Chang WT; Lee CM; Lee YT
Clin Chim Acta; 2008 Feb; 388(1-2):78-83. PubMed ID: 17964293
[TBL] [Abstract][Full Text] [Related]
20. APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese.
Chien KL; Fang WH; Wen HC; Lin HP; Lin YL; Lin SW; Wu JH; Kao JT
Clin Chim Acta; 2008 Apr; 390(1-2):56-62. PubMed ID: 18206649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
